share_log

BRIEF-Halozyme Reports Proposed Offering Of $500 Mln Of Convertible Senior Notes Due 2027

路透社 ·  Feb 24, 2021 05:36
Feb 23 (Reuters) - Halozyme Therapeutics Inc :
   * HALOZYME THERAPEUTICS, INC. ANNOUNCES PROPOSED OFFERING OF $500 MILLION OF CONVERTIBLE SENIOR NOTES DUE 2027
   * HALOZYME THERAPEUTICS - INTENDS TO OFFER, SUBJECT TO MARKET CONDITIONS AND OTHER FACTORS, $500 MILLION OF CONVERTIBLE SENIOR NOTES DUE 2027

Source text for Eikon:  Further company coverage:

((Reuters.Briefs@thomsonreuters.com;)
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment